Zobrazeno 1 - 10
of 30
pro vyhledávání: '"H F, Rauschecker"'
Publikováno v:
Der Onkologe. 8:867-873
Lokalrezidive verschlechtern die Prognose und sollten durch eine optimale Primartherapie moglichst verhindert werden. Beim isolierten Lokalrezidiv (ohne Fernmetastasen) ist eine konsequente lokale Therapie mit kurativer Intention (Operation, Strahlen
Autor:
Willi Sauerbrei, H. F. Rauschecker, Wolfgang Gatzemeier, Alfred Schauer, C. Schmoor, Martin Schumacher, Rolf Sauer
Publikováno v:
European Journal of Cancer. 34:315-323
In this report, the results of the first controlled clinical trial on breast cancer in Germany, begun in 1983, are presented after a median follow-up of 8 years. Four-year results have been previously published. In pT1 N0 M0 breast cancer, mastectomy
Autor:
H. F. Rauschecker, Willi Sauerbrei, C. Beyerle, Manfred Olschewski, Claudia Schmoor, K. Hübner, Martin Schumacher, Hans Bojar, R. L. A. Neumann, G. Bastert
Publikováno v:
Journal of Clinical Oncology. 12:2086-2093
PURPOSE In 1984, the German Breast Cancer Study Group (GBSG) started a multicenter randomized clinical trial to compare the effectiveness of three versus six cycles of 500 mg/m2 cyclophosphamide, 40 mg/m2 methotrexate, and 600 mg/m2 fluorouracil (CMF
Autor:
T, Liersch, W, Gatzemeier, P, Scharnberg, B, Jürgens, B, Wörmann, H, Becker, H F, Rauschecker, W, Hiddemann, G G, Wulf
Publikováno v:
Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress. 115
The analysis of tissue specific gene expression by reverse transcription based RT/PCR methods is currently evaluated as a method for the detection of tumor cell dissemination in patients with cancer. Breast cancer tissues express PTHrP and the level
Autor:
H F, Rauschecker
Publikováno v:
Zentralblatt fur Chirurgie. 123
The GBSG is actually running two studies on breast cancer therapy: GBSG-5 addresses the necessity of radiotherapy following tumor removal, in breast preserving treatment of pT1N0M0 G1 breast cancer. The other question to be answered in a randomised 2
Autor:
H F, Rauschecker, W, Sauerbrei, W, Gatzemeier, R, Sauer, A, Schauer, C, Schmoor, M, Schumacher
Publikováno v:
European journal of cancer (Oxford, England : 1990). 34(3)
In this report, the results of the first controlled clinical trial on breast cancer in Germany, begun in 1983, are presented after a median follow-up of 8 years. Four-year results have been previously published. In pT1 N0 M0 breast cancer, mastectomy
Autor:
H F, Rauschecker
Publikováno v:
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]. 174(1)
Publikováno v:
Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress. 114
In the prospective nonrandomized observation study "Therapy of Small Breast Cancer", which was the first multicenter trial on breast cancer ever conducted in Germany, mastectomy (303 cases) was compared with breast-preservation therapy (733 cases) in
Autor:
T, Liersch, B, Wörmann, H F, Rauschecker, C C, Kaufmann, W, Hiddemann, H, Becker, W, Gatzemeier
Publikováno v:
Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress. 114
Since 10/1994 the Interdisziplinäre Kurzzeit-Onkologie (IKO) is an outpatient department for the treatment of patients with cancer used by the departments of hematology/oncology and surgery. Between 09/1995 and 02/1997, 818 patients received 2024 cy
Autor:
M H, Seegenschmiedt, W, Sauerbrei, R, Sauer, M, Schumacher, A, Schauer, H F, Rauschecker, H, Dinkloh, E, Dühmke, K D, Haase, W, Haase
Publikováno v:
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]. 169(6)
Within six years between November 1983 and December 1989 the German Breast Cancer Study Group (GBSG) conducted a prospective multicenter trial on the treatment of pT1 pN0 M0 breast carcinoma. Out of 1036 eligible patients from 69 hospitals, a total o